drugset / Trial / NCT00617903

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

NCT00617903

Phase 2 Completed 83 enrolled LEO Pharma Bayer · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This exploratory study is being performed to determine whether a new form formulation of azelaic acid 15% is effective in the treatment of papulopustular rosecea.

Timeline

Start
2008-01
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule 15 % Topical

Indications